(Alliance News) - Ovoca Bio PLC on Wednesday said Non-Executive Director Nikolay Myasoyedov intends to step down from the board with immediate effect for personal reasons.
The pharmaceutical company said Myasoyedov will remain a director of IVIX LLC, a subsidiary of Ovoca, and will continue to provide his expertise on the development of its investigational drug, Libicore.
"We are pleased that Nikolay will continue to serve as a director of IVIX, where his extensive scientific experience and knowledge will be a valuable resource as we progress with the development programme for Libicore," said Ovoca Chief Executive Kirill Golovanov.
Ovoca shares were trading 10% lower on Wednesday in London at 12.10 pence each.
Ovoca Bio (OVB)